Jacobus Pharmaceutical Co., Inc. – Trademark Portfolio

Entity Type: 03

Jacobus Pharmaceutical Co., Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RUZURGI. The owner is based in Princeton, NJ.

PO 5290

37 Cleveland Lane

Princeton, NJ 08540

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RUZURGI
RUZURGI
Registered 2017
JUNDAPY
JUNDAPY
Abandoned 2017
UDAPKA
UDAPKA
Abandoned 2017
YUCANDAP
YUCANDAP
Abandoned 2017
KALPRIN
KALPRIN
Abandoned 2014
KALIDIN
KALIDIN
Abandoned 2014

Trademark Classifications

Jacobus Pharmaceutical Co., Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Jacobus Pharmaceutical Co., Inc. have?

Jacobus Pharmaceutical Co., Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned.

What trademark classes does Jacobus Pharmaceutical Co., Inc. file in?

Jacobus Pharmaceutical Co., Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jacobus Pharmaceutical Co., Inc.'s most well-known trademarks?

Jacobus Pharmaceutical Co., Inc.'s registered trademark portfolio includes well-known marks such as RUZURGI. These are among 1 currently registered trademark in the portfolio.

What is Jacobus Pharmaceutical Co., Inc.'s trademark registration success rate?

Jacobus Pharmaceutical Co., Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.